We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Domain Therapeutics Opens a North American Subsidiary at Montreal's NEOMED Institute

News   Jan 21, 2014

 
Domain Therapeutics Opens a North American Subsidiary at Montreal's NEOMED Institute
 
 
 

RELATED ARTICLES

Making Custom-designed Natural Products

News

Microorganisms often assemble natural products similar to industrial assembly lines. Certain enzymes, non-ribosomal peptide synthetases (NRPS) play a key role in this process. Biotechnologists have now discovered how these enzymes interact with each other, bringing them one step closer to their goal of engineering peptide natural products.

READ MORE

On-demand, Adaptable and Automated Biopharmaceutical Manufacturing

News

Having the ability to produce small batches of drugs makes precision medicine a reality, and accelerates drug development.

READ MORE

Two-Pronged Approach Reveals Drug Combination for Lung Cancer

News

Moffitt Cancer Center researchers are combining the large-scale study of proteins (proteomics) with a new data integration method to identify a previously unknown mechanism for midostaurin in lung cancer. Midostaurin is a drug approved by the FDA for the treatment of acute myeloid leukemia and advanced systemic mastocytosis.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE